Is Cardinal Health Inc (CAH) overvalued? · P/E 35, rev $222.58B
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
This page asks whether Cardinal Health Inc (CAH) looks expensive on cached numbers — not a short thesis.
Latest reported CAH revenue for 2025-06-30 was $222.58B. Net income was $1.57B. Revenue was down 1.9% from 2024-06-30 to 2025-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CAH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CAH stock page for the full model, not this heading.
Not investment advice.